Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika Plc

Ilika’s Stereax solid state batteries will be showcased by Cirtec Medical at Medical Technology Ireland.

The event will take place from 23 to 24 September 2026 at Galway Racecourse in Ireland. Cirtec Medical will attend the show and present Ilika’s Stereax batteries as part of its medical technology offering.

Stereax batteries are designed for small, high-value applications where size, reliability and energy performance matter. Medical devices are a clear fit for that proposition, particularly where developers need compact power sources for advanced device designs. The presence of Stereax at a medical technology event therefore supports Ilika’s positioning in a market where technical specifications and supply-chain confidence are important.

Medical Technology Ireland brings together companies involved in medical device design, development and manufacturing.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search